ABUS vs PEG
Arbutus Biopharma Corp (ABUS) versus Public Service Enterprise Group Inc (PEG) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported PEG revenue for 2024-12-31 was $10.29B. Net income was $1.77B. Revenue was down 8.4% from 2023-12-31 to 2024-12-31. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Not investment advice. Open the ABUS and PEG stock pages for the full models.
Not investment advice.